Hypoxia-inducible factor 1:: regulation by hypoxic and non-hypoxic activators

被引:420
作者
Déry, MAC [1 ]
Michaud, MD [1 ]
Richard, DE [1 ]
机构
[1] Univ Laval, Hot Dieu Quebec, Ctr Rech, Dept Med, Quebec City, PQ G1R 2J6, Canada
关键词
hypoxia; HIF-1; cancer; cardiovascular;
D O I
10.1016/j.biocel.2004.08.012
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Oxygen availability is crucial for cellular metabolism. Hypoxia-inducible factor 1 (HIF-1) is the major oxygen homeostasis regulator. Under normoxic conditions, HIF- 1 is rapidly degraded by the proteasome. However, under hypoxic conditions, HIF- I is stabilized and permits the activation of genes essential to cellular adaptation to low oxygen conditions. These genes include the vascular endothelial growth factor (VEGF), erythropoietin and glucose transporter-1. There is increasing evidence showing that HIF- I is also implicated in biological functions requiring its activation under normoxic conditions. Amongst others, growth factors and vascular hormones are implicated in this normoxic activation. In this review, we will focus on differences between hypoxic and non-hypoxic induction and activation of HIF- 1. We will also discuss the biological functions of HIF- I associated with these two induction pathways. The clear understanding of both HIF- I activation mechanisms could have a major impact in cancer and vascular disease. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:535 / 540
页数:6
相关论文
共 20 条
  • [1] HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1α in normoxia
    Berra, E
    Benizri, E
    Ginouvès, A
    Volmat, V
    Roux, D
    Pouysségur, J
    [J]. EMBO JOURNAL, 2003, 22 (16) : 4082 - 4090
  • [2] Hypoxic gene activation by lipopolysaccharide in macrophages:: Implication of hypoxia-inducible factor 1α
    Blouin, CC
    Pagé, EL
    Soucy, GM
    Richard, DE
    [J]. BLOOD, 2004, 103 (03) : 1124 - 1130
  • [3] HIF-1α is essential for myeloid cell-mediated inflammation
    Cramer, T
    Yamanishi, Y
    Clausen, BE
    Förster, I
    Pawlinski, R
    Mackman, N
    Haase, VH
    Jaenisch, R
    Corr, M
    Nizet, V
    Firestein, GS
    Gerber, HP
    Ferrara, N
    Johnson, RS
    [J]. CELL, 2003, 112 (05) : 645 - 657
  • [4] Feldser D, 1999, CANCER RES, V59, P3915
  • [5] Thrombin activates the hypoxia-inducible factor-1 signaling pathway in vascular smooth muscle cells role of the p22phox-containing NADPH oxidase
    Görlach, A
    Diebold, I
    Schini-Kerth, VB
    Berchner-Pfannschmidt, U
    Roth, U
    Brandes, RP
    Kietzmann, T
    Busse, R
    [J]. CIRCULATION RESEARCH, 2001, 89 (01) : 47 - 54
  • [6] Interleukin-1β and tumor necrosis factor-α stimulate DNA binding of hypoxia-inducible factor-1
    Hellwig-Bürgel, T
    Rutkowski, K
    Metzen, E
    Fandrey, J
    Jelkmann, W
    [J]. BLOOD, 1999, 94 (05) : 1561 - 1567
  • [7] Regulation of hypoxia-inducible factor 1α is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway
    Huang, LE
    Gu, J
    Schau, M
    Bunn, HF
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (14) : 7987 - 7992
  • [8] LANCASTER DE, 2004, BIOCH J
  • [9] Hypoxia-inducible factor-1α mRNA contains an internal ribosome entry site that allows efficient translation during normoxia and hypoxia
    Lang, KJD
    Kappel, A
    Goodall, GJ
    [J]. MOLECULAR BIOLOGY OF THE CELL, 2002, 13 (05) : 1792 - 1801
  • [10] 2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF
    Mabjeesh, NJ
    Escuin, D
    LaVallee, TM
    Pribluda, VS
    Swartz, GM
    Johnson, MS
    Willard, MT
    Zhong, H
    Simons, JW
    Giannakakou, P
    [J]. CANCER CELL, 2003, 3 (04) : 363 - 375